Acuta Capital Partners’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.96M	Sell	439,464 -15,363	-3%	-$71.4K	1.39%	18
2025 Q4	$2.5M	Hold	454,827	–	–	1.7%	15
2025 Q3	$1.49M	Sell	454,827 -30,842	-6%	-$87.3K	1.54%	17
2025 Q2	$1.12M	Buy	+485,669	New	+$1.06M	1.57%	18
2025 Q1	–	Sell	-884,244	Closed	-$1.53M	–	44
2024 Q4	$1.53M	Sell	884,244 -1,234,748	-58%	-$2.56M	1.54%	22
2024 Q3	$4.26M	Sell	2,118,992 -211,945	-9%	-$465K	3.45%	10
2024 Q2	$5.22M	Sell	2,330,937 -1,002,396	-30%	-$2.92M	4.4%	8
2024 Q1	$9.57M	Sell	3,333,333 -256,000	-7%	-$533K	6.21%	4
2023 Q4	$6.35M	Sell	3,589,333 -238,593	-6%	-$476K	3.58%	10
2023 Q3	$12.1M	Buy	+3,827,926	New	+$7.15M	8.11%	1